Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effects of Stimulant Medication on Disruptive Behavior, Choice, and Preference in Children and Adolescents Exhibiting Disruptive Behavior

NCT03420339 is registered in ClinicalTrials.gov with Matthew J O'Brien, PhD, BCBA-D as lead sponsor.

NCT NCT03420339
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03420339 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effects of Stimulant Medication on Disruptive Behavior, Choice, and Preference in Children and Adolescents Exhibiting Disruptive Behavior
Lead sponsor
Matthew J O'Brien, PhD, BCBA-D
Phase
Phase 4
Overall status
Recruiting
Start date
October 1, 2018
Completion date
August 1, 2027
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder, problem behavior